In plain English
AstraZeneca PLC develops and sells prescription medicines, focusing on treatments for serious diseases such as eosinophilic esophagitis…
Equity · NASDAQ · USD
AZN
AstraZeneca PLC
$160.74
Today
−$1.96-1.20%
vs previous close
Quote
- Open
- $163.02
- High
- $163.96
- Low
- $159.40
- Prev close
- $162.70
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Size
- Large-cap
- Market cap
- $186.2B
- Shares out
- 1.55B
- Country
- GB
- IPO
- Sep 21, 2007
- Exchange
- NASDAQ
- Website
- astrazeneca.com
Price chart Pro
Loading chart…
Loading chart…
Company briefing
What AZN is
Plain English context — why the name shows up in the news, and what to watch next. Not a tip.
Latest on this name
Insights & deeper context
3 recent cards — open any for the full deeper dive.
AstraZeneca, Amgen Score Phase 3 Win in Debilitating Swallowing Disease
In brief
Tezspire’s Phase 3 win positions it as the first approved treatment for EoE, potentially opening a sizable new market for AstraZeneca and Amgen.
AstraZeneca, Amgen Report Phase III Results For TEZSPIRE In Eosinophilic Esophagitis; TEZSPIRE Meets Key Endpoints In Phase III CROSSING Trial
In brief
TEZSPIRE’s Phase III trial shows sustained, clinically meaningful benefits in EoE, supporting its future development and market potential.
Cullinan Therapeutics Zipalertinib Combo Clears Key Phase 3 Hurdle As First-Line Lung Cancer Treatment Option Takes Shape
In brief
Cullinan Therapeutics' zipalertinib combo cleared a key Phase 3 hurdle, showing strong efficacy and tolerability in a first-line lung cancer treatment option.
Filings & reports
SEC and filing-linked cards
No filings tagged yet
Filing-linked cards for AZN will show up here when available.
Indexes like the S&P 500 are shown via liquid ETFs (e.g. SPY). Company profile and quotes use live market data when available.